Gene · 10769
Papers1,578
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,578
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FAM117B Promotes Colorectal Cancer Progression by Enhancing DYRK1A-mediated Phosphorylation of PLK2. | Cell Biol Int | 2026 | 41504297 | PubTator, text mining | PubMed |
| Consensus Pharmacological Interactions for PLK2 Inhibitor Identification in Colorectal Cancer Treatment. | J Chem Inf Model | 2026 | 41405409 | PubTator, text mining | PubMed |
| BI-2536 attenuates IPF progression by inhibiting the PLK2/JNK/SP1 Signaling pathway in AT2 cells. | Int Immunopharmacol | 2026 | 41237696 | PubTator, text mining | PubMed |
| Diabetic kidney disease: exploring mechanistic depths and the future of pharmacological intervention. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 40828323 | PubTator, text mining | PubMed |
| Low expression of polo-like kinase 2 predicts high postoperative seizure recurrence in glioma-related epilepsy. | Am J Transl Res | 2025 | 41415065 | PubTator, text mining | PubMed |
| Identification and validation of SUN modification-related anti-PD-1 immunotherapy-resistance signatures to predict prognosis and immune microenvironment status in glioblastoma. | BMC Cancer | 2025 | 41318472 | PubTator, text mining | PubMed |
| Integrative analysis of polo-like kinase family identifies a prognostic signature and validates PLK2 as a therapeutic target in glioma. | Transl Cancer Res | 2025 | 41234853 | PubTator, text mining | PubMed |
| Navigating sports nutrition: athlete and coach experiences from a 16-week personalized intervention. | Nutr Metab (Lond) | 2025 | 41088387 | PubTator, text mining | PubMed |
| Identification of radiation-sensitive genes as biomarkers for biodosimetry: an ex vivo analysis of TNFRSF10B, ZMAT3, POLH, and PLK2 in human blood samples. | BMC Med Genomics | 2025 | 41074151 | PubTator, text mining | PubMed |
| Supercharged NK cells: a unique population of NK cells capable of differentiating stem cells and lysis of MHC class I high differentiated tumors. | Cell Death Dis | 2025 | 40890122 | PubTator, text mining | PubMed |
| The Role of Obesity in the Regulation of Immunosuppressive Cell Infiltration and Immunosurveillance in Cancers. | Diseases | 2025 | 40863244 | PubTator, text mining | PubMed |
| The Dark Side of Vascular Aging: Noncoding Ribonucleic Acids in Heart Failure with Preserved Ejection Fraction. | Cells | 2025 | 40862748 | PubTator, text mining | PubMed |
| High-throughput virtual screening, identification and in vitro biological evaluation of novel inhibitors of PLK1 and NRP1. | J Enzyme Inhib Med Chem | 2025 | 40820676 | PubTator, text mining | PubMed |
| Gene transcription, neurotransmitter, and neurocognition signatures of brain structural-functional coupling variability. | Nat Commun | 2025 | 40817330 | PubTator, text mining | PubMed |
| Genomic landscapes of breast cancer in African populations: a systematic review. | NPJ Breast Cancer | 2025 | 40813389 | PubTator, text mining | PubMed |
| Transcriptome fingerprinting of aberrant fibroblast activation unlocks effective therapeutics to tackle cardiac fibrosis. | Sci Adv | 2025 | 40802773 | PubTator, text mining | PubMed |
| Characterization and Regulation of Alpha-Synuclein Phosphorylation in Enteric Neurons. | Eur J Neurosci | 2025 | 40673719 | PubTator, text mining | PubMed |
| Improvement of sports nutrition knowledge by a dual method education program in track and field athletes: a randomized controlled trial. | J Int Soc Sports Nutr | 2025 | 40525378 | PubTator, text mining | PubMed |
| Structural regulation of PLK1 activity: implications for cell cycle function and drug discovery. | Cancer Gene Ther | 2025 | 40379873 | PubTator, text mining | PubMed |
| Using novel oxidative phosphorylation inhibitors to attenuate drug resistance in human gliomas. | EXCLI J | 2025 | 40376435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10769/papers?page=2